FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma-Reference-Cited by-同舟云学术

FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma

Published:2024-06-02 Issue: Volume: Page:
ISSN:1360-8185
Container-title:Apoptosis
language:en
Short-container-title:Apoptosis

Author:

Wang Qingbin,Tan Wenliang,Zhang Ziyu,Chen Qiuju,Xie Zhiqin,Yang Lei,Tang Chenwei,Zhuang Hongkai,Wang Bingkun,Jiang Jiahao,Ma Xiaowu,Wang Wentao,Hua Yonglin,Shang Changzhen,Chen Yajin

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

the program of Guangdong Provincial Clinical Research Center for Digestive Diseases

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10495-024-01982-1.pdf

Reference44 articles.

1. Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. https://doi.org/10.3322/caac.21660

2. Chen L, Han X (2015) Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Investig 125:3384–3391. https://doi.org/10.1172/jci80011

3. Schildberg F, Klein S, Freeman G, Sharpe A (2016) Coinhibitory pathways in the B7-CD28 ligand-receptor family. Immunity 44:955–972. https://doi.org/10.1016/j.immuni.2016.05.002

4. Qin S, Ren Z, Meng Z, Chen Z, Chai X, Xiong J et al (2020) Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial. Lancet Oncol 21:571–580. https://doi.org/10.1016/S1470-2045(20)30011-5

5. Herbst RS, Baas P, Kim D-W, Felip E, Pérez-Gracia JL, Han J-Y et al (2016) Pembrolizumab versus Docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet (London England) 387:1540–1550. https://doi.org/10.1016/S0140-6736(15)01281-7